It sounded to me as though Sean Hehir conceded they were unable to achieve market penetration with Akida 1.0 as there already existed good enough solutions in those areas where the Akida 1.0 technology was focused on and they were unable to displace the incumbents.
- Forums
- ASX - By Stock
- BRN
- Quarterly Investor Podcast Q1 2023
Quarterly Investor Podcast Q1 2023, page-2
- There are more pages in this discussion • 163 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
28.0¢ |
Change
0.035(14.3%) |
Mkt cap ! $505.7M |
Open | High | Low | Value | Volume |
25.0¢ | 28.0¢ | 24.5¢ | $4.472M | 17.12M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 106205 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.0¢ | 861865 | 37 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 54437 | 0.275 |
19 | 339758 | 0.270 |
21 | 613168 | 0.265 |
23 | 695735 | 0.260 |
18 | 415573 | 0.255 |
Price($) | Vol. | No. |
---|---|---|
0.280 | 732882 | 35 |
0.285 | 640022 | 12 |
0.290 | 545795 | 16 |
0.295 | 694210 | 18 |
0.300 | 1176498 | 23 |
Last trade - 14.51pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
27.0¢ |
  |
Change
0.035 ( 10.0 %) |
|||
Open | High | Low | Volume | ||
25.0¢ | 28.0¢ | 24.5¢ | 14008470 | ||
Last updated 15.11pm 06/05/2024 ? |
Featured News
BRN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online